These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11198052)

  • 1. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice.
    Aitchison KJ; Jann MW; Zhao JH; Sakai T; Zaher H; Wolff K; Collier DA; Kerwin RW; Gonzalez FJ
    J Psychopharmacol; 2000; 14(4):353-9. PubMed ID: 11198052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and on insulin and lipid elevations and insulin resistance in clozapine-treated patients.
    Melkersson KI; Scordo MG; Gunes A; Dahl ML
    J Clin Psychiatry; 2007 May; 68(5):697-704. PubMed ID: 17503978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement.
    van der Weide J; Steijns LS; van Weelden MJ
    Pharmacogenetics; 2003 Mar; 13(3):169-72. PubMed ID: 12618594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice.
    Derkenne S; Curran CP; Shertzer HG; Dalton TP; Dragin N; Nebert DW
    Pharmacogenet Genomics; 2005 Jul; 15(7):503-11. PubMed ID: 15970798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
    Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
    J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients.
    Doude van Troostwijk LJ; Koopmans RP; Vermeulen HD; Guchelaar HJ
    Eur J Pharm Sci; 2003 Dec; 20(4-5):451-7. PubMed ID: 14659489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia.
    Islam F; Maciukiewicz M; Freeman N; Huang E; Tiwari A; Mulsant BH; Pollock BG; Remington G; Kennedy JL; Müller DJ; Rajji TK
    J Psychopharmacol; 2021 Jan; 35(1):31-39. PubMed ID: 33143542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of green tea extract administration on the pharmacokinetics of clozapine in rats.
    Jang EH; Choi JY; Park CS; Lee SK; Kim CE; Park HJ; Kang JS; Lee JW; Kang JH
    J Pharm Pharmacol; 2005 Mar; 57(3):311-6. PubMed ID: 15807986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis.
    Na Takuathung M; Hanprasertpong N; Teekachunhatean S; Koonrungsesomboon N
    Acta Psychiatr Scand; 2019 Jan; 139(1):15-25. PubMed ID: 30112761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2.
    Buters JT; Tang BK; Pineau T; Gelboin HV; Kimura S; Gonzalez FJ
    Pharmacogenetics; 1996 Aug; 6(4):291-6. PubMed ID: 8873215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
    Kootstra-Ros JE; Smallegoor W; van der Weide J
    Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method.
    Jerling M; Merlé Y; Mentré F; Mallet A
    Br J Clin Pharmacol; 1997 Nov; 44(5):447-53. PubMed ID: 9384461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.
    Carrillo JA; Herraiz AG; Ramos SI; Benítez J
    J Clin Psychopharmacol; 1998 Aug; 18(4):311-6. PubMed ID: 9690697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia.
    Frazier JA; Cohen LG; Jacobsen L; Grothe D; Flood J; Baldessarini RJ; Piscitelli S; Kim GS; Rapoport JL
    J Clin Psychopharmacol; 2003 Feb; 23(1):87-91. PubMed ID: 12544379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
    Bondolfi G; Morel F; Crettol S; Rachid F; Baumann P; Eap CB
    Ther Drug Monit; 2005 Aug; 27(4):539-43. PubMed ID: 16044115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of clozapine and desmethylclozapine between blood and brain in rats.
    Weigmann H; Härtter S; Fischer V; Dahmen N; Hiemke C
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):253-6. PubMed ID: 10208296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence from a population pharmacokinetics analysis for a major effect of CYP1A2 activity on inter- and intraindividual variations of clozapine clearance.
    Dailly E; Urien S; Chanut E; Claudel B; Guerra N; Femandez C; Jolliet P; Bourin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):699-703. PubMed ID: 12188102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.
    Bertilsson L; Carrillo JA; Dahl ML; Llerena A; Alm C; Bondesson U; Lindström L; Rodriguez de la Rubia I; Ramos S; Benitez J
    Br J Clin Pharmacol; 1994 Nov; 38(5):471-3. PubMed ID: 7893591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a future for
    Ruan CJ; de Leon J
    Pharmacogenomics; 2020 Apr; 21(6):369-373. PubMed ID: 32308139
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
    Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
    Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.